The list below includes funding opportunities specifically targeting COVID-19 and its detection, prevention and treatment. If you have any questions or otherwise need support, please contact the Office of Research Development & Strategic Initiatives. If you are working on COVID-19 related research, please complete this short form so that we can help connect you with funding agencies and program managers.
We are doing our best to keep this information accurate, but check the full solicitations for deadline updates.
Sponsor |
Grant/Program Name |
Sponsor Deadline |
Fast Grants - Emergent Ventures |
Fast Funding for COVID-19 Science Prior to submission please confer with our Commercialization EPI-Center Office if you have questions about IP or confidentiality. |
See Solicitation |
CDC |
Conducting Research to Inform Pandemic Response and Recovery of Emergency-Affected Populations by Determining Public Health Needs, Improving Methods, and Integrating Services to Mitigate Morbidity and Mortality - RFA-GH-21-004 (Also see Limited Submissions) |
February 18, 2021 |
CRC |
Pandemic/COVID19 Science, Technology and Social Impact - RFP-20-04 |
See Solicitation - applications reviewed on a rolling basis |
Dept of Commerce |
FY 2020 EDA Public Works and Economic Adjustment Assistance Programs including CARES Act Funding - PWEAA2020 |
See Solicitation for ongoing deadlines |
Dept. of State |
COVID-19 Private Sector Engagement & Partnership Fund - SFOP0007088 |
May 28, 2021 |
Google |
Apply for Google Cloud Research Credits |
See solicitation - applications reviewed on a rolling basis |
Jacob & Valeria Langeloth Foundation |
COVID-19 Rapid Response Fund |
LOI – December 15, 2020 Proposal Deadline – February 15, 2021 |
NIH - NIAD |
Notice of Special Interest (NOSI): Availability of Emergency Awards for Limited Clinical Trials to Evaluate Therapeutic and Vaccine Candidates Against SARS-CoV-2 - NOT-AI-20-065 |
See Solicitation - September 1, 2021 |
NIH - NIAID - NIA |
Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required) - PAR-20-139 |
See Solicitation - Various Deadlines thru January 2023 |
NIH - NIDA |
Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus - NOT-DA-20-047 |
March 31, 2021 |
NIH |
Notice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Need - NOT-TR-20-011 |
See solicitation - Expiration Date July 10, 2021 |
NIH |
Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional) - PA-18-935 |
See solicitation - Expiration Date January 25, 2022 |
NIH |
Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) - PA-18-591 |
Applications accepted through February 6, 2021 |
NIH |
Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional) - PA-20-135 |
See solicitation - Expiration Date March 10, 2023 |
NIH |
Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 - Clinical Trial Optional) - PAR-20-243 |
March 2, 2021 |
Robert Wood Johnson Foundation |
Pioneering Ideas: Exploring the Future to Build a Culture of Health |
See Solicitation - Deadline on a rolling basis |